Jeffrey H Meyer Selected Research

Dopamine (Intropin)

1/2023	Monoamine Oxidase B (MAO-B): A Target for Rational Drug Development in Schizophrenia Using PET Imaging as an Example.
3/2007	PET and SPECT imaging in psychiatric disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey H Meyer Research Topics

Disease

29	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 01/2003
9	Gliosis 11/2023 - 09/2017
8	Postpartum Depression (Post-Natal Depression) 01/2021 - 05/2010
7	Antisocial Personality Disorder (Antisocial Personality) 01/2019 - 10/2015
5	Mental Disorders (Mental Disorder) 01/2021 - 07/2012
5	Mood Disorders (Mood Disorder) 01/2021 - 08/2014
5	Parkinson Disease (Parkinson's Disease) 01/2021 - 09/2008
5	Neuroinflammatory Diseases 12/2020 - 11/2014
4	Bipolar Disorder (Manic Depressive Psychosis) 01/2023 - 01/2018
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023 - 01/2021
3	Schizophrenia (Dementia Praecox) 01/2023 - 03/2007
3	Psychotic Disorders (Schizoaffective Disorder) 01/2023 - 02/2017
3	Alcoholism (Alcohol Abuse) 01/2021 - 05/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 03/2012
2	Treatment-Resistant Depressive Disorder 01/2023 - 01/2020
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2021 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 11/2008
2	Multiple System Atrophy 01/2020 - 09/2017
2	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2017 - 01/2016
2	Encephalitis (Encephalitis, Rasmussen) 01/2017 - 03/2015
1	Premenstrual Dysphoric Disorder 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Autism Spectrum Disorder 01/2022
1	Huntington Disease (Huntington's Disease) 01/2021
1	Tourette Syndrome (Tourette's Syndrome) 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	Anxiety Disorders (Anxiety Disorder) 01/2021
1	Anorexia Nervosa 01/2021
1	Tobacco Use Disorder (Nicotine Dependence) 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Substance-Related Disorders (Drug Abuse) 09/2020
1	Hypertensive Crisis 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Cocaine-Related Disorders (Cocaine Addiction) 01/2018
1	Heroin Dependence (Heroin Abuse) 01/2018
1	Personality Disorders (Personality Disorder) 01/2018
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 09/2017
1	Parkinsonian Disorders (Parkinsonism) 09/2017
1	Prodromal Symptoms 01/2017
1	Seasonal Affective Disorder 01/2016
1	Weight Loss (Weight Reduction) 03/2015
1	Anorexia 03/2015
1	Anhedonia 03/2015
1	Disease Progression 01/2015
1	Nervous System Diseases (Neurological Disorders) 11/2014
1	Dementia (Dementias) 08/2014
1	Hyperphagia (Overeating) 03/2014

Drug/Important Bio-Agent (IBA)

23	Monoamine Oxidase (MAO)IBA 01/2023 - 12/2009
17	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2011
6	Tuberculin (PPD)IBA 01/2021 - 06/2014
6	Antidepressive Agents (Antidepressants)IBA 01/2020 - 03/2007
5	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2023 - 03/2007
5	EnzymesIBA 01/2023 - 11/2012
5	4-aminospiroperidolIBA 01/2019 - 10/2015
4	Protons (Proton)IBA 01/2023 - 01/2018
4	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 01/2015
4	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2017 - 12/2004
4	Harmine (Telepathine)IBA 10/2015 - 03/2012
3	SL25.1188IBA 01/2022 - 01/2019
3	Minocycline (Cyclops)FDA LinkGeneric 01/2021 - 01/2020
3	Serotonin (5 Hydroxytryptamine)IBA 09/2020 - 01/2003
3	AntioxidantsIBA 01/2020 - 01/2018
3	Glutathione (Reduced Glutathione)IBA 01/2018 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2020
2	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 03/2007
2	LigandsIBA 10/2021 - 07/2008
2	CannabinoidsIBA 01/2021 - 01/2021
2	Celecoxib (Celebrex)FDA Link 10/2020 - 01/2020
2	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 09/2017 - 08/2015
2	GlucocorticoidsIBA 01/2017 - 07/2012
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2009 - 09/2007
2	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 09/2008 - 09/2007
1	Simvastatin (Zocor)FDA LinkGeneric 01/2023
1	Glutamine (L-Glutamine)FDA Link 01/2023
1	LipidsIBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2023
1	Glutamic Acid (Glutamate)FDA Link 01/2023
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Hormones (Hormone)IBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 09/2020
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2020
1	DinoprostIBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2018
1	Cocaine (Cocaine HCl)IBA 01/2018
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 12/2017
1	Oxidoreductases (Dehydrogenase)IBA 09/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017
1	FluorineIBA 03/2015
1	PK 11195 (PK11195)IBA 01/2015
1	6- (2- methyl- 4- (2- naphthyl)- 1,2,3,4- tetrahydroisoquinolin- 7- yl)pyridazin- 3- amineIBA 06/2014

Therapy/Procedure

4	Therapeutics 11/2023 - 03/2012
1	Precision Medicine 10/2020
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2018